486 related articles for article (PubMed ID: 11476767)
1. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
Genazzani AD; Stomati M; Strucchi C; Puccetti S; Luisi S; Genazzani AR
Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
[TBL] [Abstract][Full Text] [Related]
2. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
Genazzani AD; Stomati M; Bernardi F; Pieri M; Rovati L; Genazzani AR
Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
[TBL] [Abstract][Full Text] [Related]
3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
4. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
Slowinska-Srzednicka J; Zgliczynski S; Jeske W; Stopinska-Gluszak U; Srzednicki M; Brzezinska A; Zgliczynski W; Sadowski Z
J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone secretion in healthy older men and women: effects of testosterone and growth hormone administration in older men.
Muniyappa R; Wong KA; Baldwin HL; Sorkin JD; Johnson ML; Bhasin S; Harman SM; Blackman MR
J Clin Endocrinol Metab; 2006 Nov; 91(11):4445-52. PubMed ID: 16926252
[TBL] [Abstract][Full Text] [Related]
6. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
Stomati M; Rubino S; Spinetti A; Parrini D; Luisi S; Casarosa E; Petraglia F; Genazzani AR
Gynecol Endocrinol; 1999 Feb; 13(1):15-25. PubMed ID: 10368794
[TBL] [Abstract][Full Text] [Related]
7. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women.
Rubino S; Stomati M; Bersi C; Casarosa E; Luisi M; Petraglia F; Genazzani AR
Maturitas; 1998 Jan; 28(3):251-7. PubMed ID: 9571601
[TBL] [Abstract][Full Text] [Related]
9. Effects of estrogen replacement therapy on dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women.
Johnson LG; Kraemer RR; Haltom R; Kraemer GR; Gaines HE; Castracane VD
Fertil Steril; 1997 Nov; 68(5):836-43. PubMed ID: 9389812
[TBL] [Abstract][Full Text] [Related]
10. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
Cano A; Castelo-Branco C; Tarín JJ
Fertil Steril; 1999 Feb; 71(2):261-7. PubMed ID: 9988395
[TBL] [Abstract][Full Text] [Related]
11. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
Morales AJ; Haubrich RH; Hwang JY; Asakura H; Yen SS
Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
[TBL] [Abstract][Full Text] [Related]
12. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
Papierska L; Rabijewski M; Kasperlik-Załuska A; Zgliczyński W
Adv Med Sci; 2012 Jun; 57(1):51-7. PubMed ID: 22430044
[TBL] [Abstract][Full Text] [Related]
13. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales AJ; Nolan JJ; Nelson JC; Yen SS
J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
[TBL] [Abstract][Full Text] [Related]
14. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
Wu X; Sallinen K; Zhou S; Su Y; Pöllänen P; Erkkola R
Fertil Steril; 2000 Apr; 73(4):730-4. PubMed ID: 10731533
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.
Harrington LB; Marck BT; Wiggins KL; McKnight B; Heckbert SR; Woods NF; LaCroix AZ; Blondon M; Psaty BM; Rosendaal FR; Matsumoto AM; Smith NL
J Thromb Haemost; 2017 Jan; 15(1):80-90. PubMed ID: 27797446
[TBL] [Abstract][Full Text] [Related]
17. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
18. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
[TBL] [Abstract][Full Text] [Related]
19. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men.
Villareal DT; Holloszy JO; Kohrt WM
Clin Endocrinol (Oxf); 2000 Nov; 53(5):561-8. PubMed ID: 11106916
[TBL] [Abstract][Full Text] [Related]
20. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
Genazzani AR; Pluchino N; Begliuomini S; Stomati M; Bernardi F; Pieri M; Casarosa E; Palumbo M; Genazzani AD; Luisi M
Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]